E.U. investigates Ozempic, Saxenda after suicidal thoughts reported
The European Medicines Agency is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients thinking about suicide or self-harm. Shares of the Danish drugmaker fell 1% on Monday following the news. An…#novonordisks #saxenda #iceland #danish #ema #ozempic #novo #novonordisk #fda #sanofi
Source: Reuters: Health - Category: Consumer Health News Source Type: news
More News: Denmark Health | Depression | Diabetes | Endocrinology | European Medicines Agency (EMA) | Health | Iceland Health | Suicide | Weight Loss